{"id":"https://openalex.org/W1964250018","doi":"https://doi.org/10.1016/0014-2999(94)90800-1","title":"The influence of 5-hydroxytryptamine re-uptake blockade on CCK receptor antagonist effects in the rat elevated zero-maze","display_name":"The influence of 5-hydroxytryptamine re-uptake blockade on CCK receptor antagonist effects in the rat elevated zero-maze","alternate_titles":[],"publication_year":1994,"publication_date":"1994-12-01","ids":{"openalex":"https://openalex.org/W1964250018","doi":"https://doi.org/10.1016/0014-2999(94)90800-1","mag":"1964250018","pmid":"https://pubmed.ncbi.nlm.nih.gov/7705440"},"language":"en","primary_location":{"id":"doi:10.1016/0014-2999(94)90800-1","doi":"https://doi.org/10.1016/0014-2999(94)90800-1","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0014-2999(94)90800-1","pdf_url":null,"source":{"id":"https://openalex.org/S187816532","display_name":"European Journal of Pharmacology","issn_l":"0014-2999","issn":["0014-2999","1879-0712"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1964250018"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111723473","display_name":"Michael J. Bickerdike","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142263535","display_name":"University of Nottingham","ror":"https://ror.org/01ee9ar58","country_code":"GB","type":"education","lineage":["https://openalex.org/I142263535"]},{"id":"https://openalex.org/I4210137227","display_name":"Queen's Medical Centre","ror":"https://ror.org/03ap6wx93","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1334287468","https://openalex.org/I4210137227"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Michael J. Bickerdike","raw_affiliation_strings":["Department of Physiology and Pharmacology, Medical School, Queen's Medical Centre, Nottingham, UK","Department of Physiology and Pharmacology, Medical School, Queen's Medical Centre, Nottingham, NG7 2UH, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Physiology and Pharmacology, Medical School, Queen's Medical Centre, Nottingham, UK","institution_ids":["https://openalex.org/I142263535","https://openalex.org/I4210137227"]},{"raw_affiliation_string":"Department of Physiology and Pharmacology, Medical School, Queen's Medical Centre, Nottingham, NG7 2UH, UK","institution_ids":["https://openalex.org/I4210137227"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112233207","display_name":"Charles Alexander Marsden","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137227","display_name":"Queen's Medical Centre","ror":"https://ror.org/03ap6wx93","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1334287468","https://openalex.org/I4210137227"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Charles A. Marsden","raw_affiliation_strings":["Department of Physiology and Pharmacology, Medical School, Queen's Medical Centre, Nottingham, NG7 2UH, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Physiology and Pharmacology, Medical School, Queen's Medical Centre, Nottingham, NG7 2UH, UK","institution_ids":["https://openalex.org/I4210137227"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089441909","display_name":"Colin Trevor Dourish","orcid":"https://orcid.org/0000-0002-3403-6330","observed_orcids":["https://orcid.org/0000-0002-3403-6330"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Colin T. Dourish","raw_affiliation_strings":["Department of Neuropharmacology, Wyeth Research (UK) Ltd, Huntercombe Lane South, Taplow, Maidenhead, Berkshire, SL6 0PH, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neuropharmacology, Wyeth Research (UK) Ltd, Huntercombe Lane South, Taplow, Maidenhead, Berkshire, SL6 0PH, UK","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110009421","display_name":"Allan Fletcher","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Allan Fletcher","raw_affiliation_strings":["Department of Neuropharmacology, Wyeth Research (UK) Ltd, Huntercombe Lane South, Taplow, Maidenhead, Berkshire, SL6 0PH, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neuropharmacology, Wyeth Research (UK) Ltd, Huntercombe Lane South, Taplow, Maidenhead, Berkshire, SL6 0PH, UK","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5111723473"],"corresponding_institution_ids":["https://openalex.org/I142263535","https://openalex.org/I4210137227"],"apc_list":{"value":3230,"currency":"USD","value_usd":3230},"apc_paid":null,"fwci":1.5899,"has_fulltext":false,"cited_by_count":46,"citation_normalized_percentile":{"value":0.8258799,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":95},"biblio":{"volume":"271","issue":"2-3","first_page":"403","last_page":"411"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.8827999830245972,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.8827999830245972,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.08349999785423279,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.018699999898672104,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/serotonin","display_name":"serotonin","score":0.8360000252723694},{"id":"https://openalex.org/keywords/cholecystokinin-receptor-antagonist","display_name":"cholecystokinin receptor antagonist","score":0.8999999761581421},{"id":"https://openalex.org/keywords/cck-a-receptor","display_name":"CCK-A receptor","score":0.875},{"id":"https://openalex.org/keywords/cck-b-receptor","display_name":"CCK-B receptor","score":0.9959999918937683},{"id":"https://openalex.org/keywords/devazepide","display_name":"devazepide","score":0.9620000123977661},{"id":"https://openalex.org/keywords/l-365-260","display_name":"L-365,260","score":0.953000009059906},{"id":"https://openalex.org/keywords/ci-988","display_name":"CI-988","score":0.9919999837875366},{"id":"https://openalex.org/keywords/zimelidine","display_name":"zimelidine","score":0.9139999747276306},{"id":"https://openalex.org/keywords/anxiolytic-effects","display_name":"anxiolytic effects","score":0.8679999709129333},{"id":"https://openalex.org/keywords/anxiety-models","display_name":"anxiety models","score":0.8410000205039978},{"id":"https://openalex.org/keywords/elevated-zero-maze","display_name":"elevated zero maze","score":0.9369999766349792}],"concepts":[{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.7426396012306213},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.6457083225250244},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5580160617828369},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.55027174949646},{"id":"https://openalex.org/C2778122271","wikidata":"https://www.wikidata.org/wiki/Q410943","display_name":"Receptor antagonist","level":4,"score":0.535753607749939},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.46938249468803406},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4603137671947479},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.38413259387016296},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.31011179089546204}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001570","descriptor_name":"Benzodiazepinones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D003975","descriptor_name":"Diazepam","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008536","descriptor_name":"Meglumine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D008536","descriptor_name":"Meglumine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009536","descriptor_name":"Niacinamide","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D009536","descriptor_name":"Niacinamide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010671","descriptor_name":"Phenylurea Compounds","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011949","descriptor_name":"Receptors, Cholecystokinin","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015031","descriptor_name":"Zimeldine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018782","descriptor_name":"Maze Learning","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D020109","descriptor_name":"Devazepide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/0014-2999(94)90800-1","doi":"https://doi.org/10.1016/0014-2999(94)90800-1","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0014-2999(94)90800-1","pdf_url":null,"source":{"id":"https://openalex.org/S187816532","display_name":"European Journal of Pharmacology","issn_l":"0014-2999","issn":["0014-2999","1879-0712"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmid:7705440","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7705440","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":40,"referenced_works":["https://openalex.org/W1965260950","https://openalex.org/W1966775719","https://openalex.org/W1976169770","https://openalex.org/W1986832734","https://openalex.org/W1988274217","https://openalex.org/W1989314580","https://openalex.org/W1991714764","https://openalex.org/W2001308670","https://openalex.org/W2002366750","https://openalex.org/W2007408817","https://openalex.org/W2008555422","https://openalex.org/W2013400253","https://openalex.org/W2016129947","https://openalex.org/W2016229528","https://openalex.org/W2023724563","https://openalex.org/W2027119507","https://openalex.org/W2031017946","https://openalex.org/W2046213581","https://openalex.org/W2048283236","https://openalex.org/W2049131160","https://openalex.org/W2056575770","https://openalex.org/W2059107166","https://openalex.org/W2066944012","https://openalex.org/W2072915505","https://openalex.org/W2073928295","https://openalex.org/W2081047290","https://openalex.org/W2082118882","https://openalex.org/W2090076189","https://openalex.org/W2090444063","https://openalex.org/W2090979724","https://openalex.org/W2091554228","https://openalex.org/W2092060676","https://openalex.org/W2093288619","https://openalex.org/W2150325253","https://openalex.org/W2161567812","https://openalex.org/W2259977864","https://openalex.org/W2281862395","https://openalex.org/W2323444743","https://openalex.org/W2341365624","https://openalex.org/W2566966744"],"related_works":["https://openalex.org/W2027508188","https://openalex.org/W1976169770","https://openalex.org/W2018332103","https://openalex.org/W2914160207","https://openalex.org/W2910853472","https://openalex.org/W2059107166","https://openalex.org/W2046213581","https://openalex.org/W1969242057","https://openalex.org/W2016229528","https://openalex.org/W2090076189"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1964250018","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
